Daewon Pharmaceutical Co. Ltd. (003220) - Total Liabilities

Latest as of March 2026: ₩325.01 Billion KRW ≈ $220.26 Million USD

Based on the latest financial reports, Daewon Pharmaceutical Co. Ltd. (003220) has total liabilities worth ₩325.01 Billion KRW (≈ $220.26 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Daewon Pharmaceutical Co. Ltd. - Total Liabilities Trend (2011–2025)

This chart illustrates how Daewon Pharmaceutical Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore 003220 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Daewon Pharmaceutical Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Daewon Pharmaceutical Co. Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Hurco Companies Inc NASDAQ:HURC	USA	$65.51 Million
Khonburi Sugar Public Company Limited BK:KBS	Thailand	฿7.45 Billion
Patria Bank SA RO:PBK	Romania	RON5.09 Billion
RTX A/S CO:RTX	Denmark	Dkr154.16 Million
DEVEX Resources Ltd AU:DEV	Australia	AU$2.79 Million
Caisse Regionale de Credit Agricole Mutuel Loire HauteLoire PA:CRLO	France	€12.54 Billion
Orian Sh.M. Ltd TA:ORIN	Israel	ILA411.77 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Daewon Pharmaceutical Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 003220 total asset value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.18	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.55	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Daewon Pharmaceutical Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Daewon Pharmaceutical Co. Ltd. (2011–2025)

The table below shows the annual total liabilities of Daewon Pharmaceutical Co. Ltd. from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩339.07 Billion ≈ $229.78 Million	+13.47%
2024-12-31	₩298.81 Billion ≈ $202.50 Million	+22.60%
2023-12-31	₩243.73 Billion ≈ $165.17 Million	+19.02%
2022-12-31	₩204.78 Billion ≈ $138.78 Million	-3.03%
2021-12-31	₩211.18 Billion ≈ $143.11 Million	+72.47%
2020-12-31	₩122.44 Billion ≈ $82.98 Million	-0.71%
2019-12-31	₩123.32 Billion ≈ $83.57 Million	+33.69%
2018-12-31	₩92.24 Billion ≈ $62.51 Million	+56.15%
2017-12-31	₩59.07 Billion ≈ $40.03 Million	+12.16%
2016-12-31	₩52.67 Billion ≈ $35.69 Million	+14.28%
2015-12-31	₩46.09 Billion ≈ $31.23 Million	-0.04%
2014-12-31	₩46.11 Billion ≈ $31.25 Million	+24.99%
2013-12-31	₩36.89 Billion ≈ $25.00 Million	+7.86%
2012-12-31	₩34.20 Billion ≈ $23.18 Million	-6.23%
2011-12-31	₩36.47 Billion ≈ $24.72 Million	--

About Daewon Pharmaceutical Co. Ltd.

KO:003220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$115.62 Million

₩170.61 Billion KRW

Market Cap Rank

#18773 Global

#882 in Korea

Share Price

₩7960.00

Change (1 day)

-0.25%

52-Week Range

₩7240.00 - ₩13450.00

All Time High

₩23535.34